Intertwined Biosciences published a 2024 review examining 367 therapeutic interventions tested in animals.
Public source
Publisher name
Public post
We keep asking animal models a question they cannot answer reliably on their own: Will this work in a human patient? A 2024 review looked at 367 therapeutic intervention…
Company
Intertwined Biosciences
Evolution. AI-Native Discovery. Therapeutics.
- Industry
- Biotechnology Research
- Location
- Cambridge, US
- Company size
- 2–10 employees
About Intertwined Biosciences
Evolution. AI-Native Discovery. Therapeutics.
See moreLatest activity
Latest activity from Intertwined Biosciences
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Terns Pharmaceuticals
Terns Pharmaceuticals published a recent paper showing that Reinforcement Learning with Metacognitive Feedback (RLMF) improves an AI's ability to signal uncertainty by up to 63% compared to standard methods.
Research & Knowledge
Raina Biosciences
Raina Biosciences published GEMORNA in Science Magazine one year ago and is now powering over 30 mRNA therapeutic programs across applications.
Research & Knowledge
RoukenBio
RoukenBio published a study in Nature Biotechnology by M Frank Erasmus et al. regarding artificial intelligence in silico affinity maturation and developable designs.
Research & Knowledge
ScienTek
ScienTek published a study assessing GPT-5 using 13,022 target-indication pairs to evaluate genetic evidence for drug development and clinical success.
Research & Knowledge
PAULING.AI